5 ALPHA REDUCTASE INHIBITORS

Course overview

THE 5-ALPHA REDUCTASE INHIBITORS (FINASTERIDE AND DUTASTERIDE) ARE A CLASS OF MEDICATION USED IN THE MANAGEMENT AND TREATMENT OF BENIGN PROSTATIC HYPERPLASIA (BPH) AND ANDROGENIC ALOPECIA (MALE PATTERN HAIR LOSS). THIS ACTIVITY OUTLINES THE INDICATIONS, ACTION, AND CONTRAINDICATIONS FOR THE 5-ALPHA REDUCTASE INHIBITORS AS VALUABLE AGENTS IN THE MANAGEMENT OF BENIGN PROSTATIC HYPERPLASIA AND ANDROGENIC ALOPECIA. THIS ACTIVITY WILL HIGHLIGHT THE MECHANISM OF ACTION, ADVERSE EVENT PROFILE, AND OTHER KEY FACTORS (E.G., OFF-LABEL USES, DOSING, PHARMACODYNAMICS, PHARMACOKINETICS, MONITORING, RELEVANT INTERACTIONS) PERTINENT FOR MEMBERS OF THE HEALTHCARE TEAM IN THE MANAGEMENT OF PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA AND RELATED CONDITIONS.